Literature DB >> 29465495

Exercise Rehabilitation for Peripheral Artery Disease: A REVIEW.

Mary M McDermott1.   

Abstract

PURPOSE: To summarize evidence regarding exercise therapy for people with lower extremity peripheral artery disease (PAD).
METHODS: Literature was reviewed regarding optimal strategies for delivering exercise interventions for people with PAD. Randomized trial evidence and recent studies were emphasized.
RESULTS: Randomized clinical trial evidence consistently demonstrates that supervised treadmill exercise improves treadmill walking performance in people with PAD. A meta-analysis of 25 randomized trials (1054 participants) concluded that supervised treadmill exercise was associated with 180 m of improvement in maximal treadmill walking distance and 128 m of improvement in pain-free walking distance compared with a control group. Three randomized trials of 493 patients with PAD demonstrated that home-based walking exercise interventions that incorporate behavioral change techniques improve walking ability in patients with PAD. Furthermore, evidence suggests that home-based walking exercise improves the 6-min walk more than supervised treadmill exercise. Upper and lower extremity ergometry also significantly improved walking endurance in PAD. The Centers for Medicare & Medicaid Services recently determined that Medicare would cover 12 wk (36 sessions) of supervised treadmill exercise for patients with PAD.
CONCLUSIONS: Supervised treadmill exercise and home-based walking exercise each improve walking ability in patients with PAD. The availability of insurance coverage for supervised treadmill exercise for patients with PAD will make supervised treadmill exercise more widely available and accessible. Home-based exercise that incorporates behavioral change technique is an effective alternative for patients unwilling or unable to attend 3 supervised exercise sessions per week.

Entities:  

Mesh:

Year:  2018        PMID: 29465495      PMCID: PMC5831500          DOI: 10.1097/HCR.0000000000000343

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil Prev        ISSN: 1932-7501            Impact factor:   2.081


  50 in total

1.  Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study.

Authors:  M M McDermott; L Fried; E Simonsick; S Ling; J M Guralnik
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

2.  Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial.

Authors:  Irena Zwierska; Richard D Walker; Sohail A Choksy; Jonathan S Male; A Graham Pockley; John M Saxton
Journal:  J Vasc Surg       Date:  2005-12       Impact factor: 4.268

3.  Effect of cilostazol prescribed in a pragmatic treatment program for intermittent claudication.

Authors:  Constance Lee; Peter R Nelson
Journal:  Vasc Endovascular Surg       Date:  2014-01-06       Impact factor: 1.089

4.  Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease.

Authors:  F A K Mazari; J A Khan; D Carradice; N Samuel; M N A Abdul Rahman; S Gulati; H L D Lee; T A Mehta; P T McCollum; I C Chetter
Journal:  Br J Surg       Date:  2011-10-21       Impact factor: 6.939

5.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.

Authors:  M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

Review 6.  Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.

Authors:  J W Stevens; E Simpson; S Harnan; H Squires; Y Meng; S Thomas; J Michaels; G Stansby
Journal:  Br J Surg       Date:  2012-10-03       Impact factor: 6.939

7.  Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Michael R Jaff; Anthony J Comerota; Michael W Steffes; Ingrid H Abrahamsen; Suzanne Goldberg; Alan T Hirsch
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

8.  Limb-specific and cross-transfer effects of arm-crank exercise training in patients with symptomatic peripheral arterial disease.

Authors:  Garry Tew; Shah Nawaz; Irena Zwierska; John M Saxton
Journal:  Clin Sci (Lond)       Date:  2009-09-21       Impact factor: 6.124

9.  Exercise training improves functional status in patients with peripheral arterial disease.

Authors:  J G Regensteiner; J F Steiner; W R Hiatt
Journal:  J Vasc Surg       Date:  1996-01       Impact factor: 4.268

10.  ROC analysis of noninvasive tests for peripheral arterial disease.

Authors:  J G Lijmer; M G Hunink; J J van den Dungen; J Loonstra; A J Smit
Journal:  Ultrasound Med Biol       Date:  1996       Impact factor: 2.998

View more
  16 in total

1.  Body-weight goals, trends, and weight-loss techniques among patients with peripheral arterial disease.

Authors:  O Addison; R Yang; M C Serra
Journal:  Nutr Health       Date:  2018-12-23

2.  Changes in exercise capacity and risk of all-cause mortality in patients with peripheral artery disease: a 10-year retrospective cohort study.

Authors:  Nicola Lamberti; Pablo Jesùs López-Soto; Franco Guerzoni; Nicola Napoli; Vincenzo Gasbarro; Paolo Zamboni; Elpiniki Tsolaki; Maria Cristina Taddia; Maria Aurora Rodríguez-Borrego; Roberto Manfredini; Nino Basaglia; Fabio Manfredini
Journal:  Intern Emerg Med       Date:  2019-08-21       Impact factor: 3.397

3.  Association Between Daily Steps at Moderate Cadence and Vascular Outcomes in Patients With Claudication.

Authors:  Andrew W Gardner; Polly S Montgomery; Ming Wang; Biyi Shen
Journal:  J Cardiopulm Rehabil Prev       Date:  2022-01-01       Impact factor: 2.081

4.  Prevention and Detection Research of Intelligent Sports Rehabilitation under the Background of Artificial Intelligence.

Authors:  Qiong Huang; Fubin Wang
Journal:  Appl Bionics Biomech       Date:  2022-05-04       Impact factor: 1.664

5.  Patient perspectives of ankle-foot orthoses for walking ability in peripheral artery disease: A qualitative study.

Authors:  Elizabeth A Choma; Ryan J Mays; Ryan L Mizner; Anita M Santasier
Journal:  J Vasc Nurs       Date:  2020-08-10

Review 6.  Assessing health-related quality of life among patients with peripheral artery disease: A review of the literature and focus on patient-reported outcome measures.

Authors:  Aishwarya Raja; John Spertus; Robert W Yeh; Eric A Secemsky
Journal:  Vasc Med       Date:  2020-12-09       Impact factor: 3.239

7.  Effects of bradykinin on voltage-gated KV 4 channels in muscle dorsal root ganglion neurons of rats with experimental peripheral artery disease.

Authors:  Qin Li; Lu Qin; Jianhua Li
Journal:  J Physiol       Date:  2021-06-11       Impact factor: 6.228

8.  Exercise Prescription Guidelines for Cardiovascular Disease Patients in the Absence of a Baseline Stress Test.

Authors:  Megan Mytinger; Rachael K Nelson; Micah Zuhl
Journal:  J Cardiovasc Dev Dis       Date:  2020-04-27

9.  Effectiveness of Home-Based Pain-Free Exercise versus Walking Advice in Patients with Peripheral Artery Disease: A Randomized Controlled Trial.

Authors:  Fabio Manfredini; Nicola Lamberti; Luca Traina; Gladiol Zenunaj; Chiara Medini; Giovanni Piva; Sofia Straudi; Roberto Manfredini; Vincenzo Gasbarro
Journal:  Methods Protoc       Date:  2021-05-10

10.  Gender Differences in Outcomes Following a Pain-Free, Home-Based Exercise Program for Claudication.

Authors:  Roberto Manfredini; Nicola Lamberti; Fabio Manfredini; Sofia Straudi; Fabio Fabbian; Maria Aurora Rodriguez Borrego; Nino Basaglia; Juan Manuel Carmona Torres; Pablo Jesus Lopez Soto
Journal:  J Womens Health (Larchmt)       Date:  2018-09-15       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.